You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – Sekisui Diagnostics announced today its Acucy Influenza A&B test has received 510(k) clearance from the US Food and Drug Administration, as well as a CLIA waiver for use on the Acucy Reader.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.